ARAVAX, a clinical-stage biotechnology company developing a novel peptide-based immunotherapy, PVX108, for the treatment of peanut allergies, raises an additional AUD 13.2 million in its Series B funding round, which was initially reported in Q1 2024. With this latest investment, the total funds raised for Series B now amount to AUD 64 million. The investment is backed by multiple investors, including Tenmile Ventures, Breakthrough Victoria, Brandon Capital, and others.

NUJ SUPER, a compliance and data management platform integrating scheduling, automation, and analytics to streamline regulatory processes, has reportedly secured AUD 4 million in Seed funding. The investment, led by Mimecast co-founder Peter Bauer, includes a combination of equity financing and a debt facility. Filings show that AUD 2.5 million of the equity investment has been secured so far.

ROSTERFY, an all-in-one volunteer management software to help manage volunteers at every stage of their journey, has reportedly raised AUD 5.5 million in investment from OIF Ventures. Filings currently show it has raised AUD 1.5 million of this in equity. 

ADVANCELL, a clinical-stage radiopharmaceutical company developing treatments to significantly improve survival and quality of life for patients with cancer, has raised AUD 117 million in an oversubscribed Series C financing round. SV Health Investors, Sanofi Ventures, Abingworth, and SymBiosis co-led this investment round.

IVO, an AI-backed legal tech platform enabling enterprises to automate contract review processes without compromising accuracy, has reportedly raised AUD 25.5 million in a Series A round. The investment was led by West Coast VC Costanoa Ventures as well as other US firms and existing investors.

UPCOVER, an online business insurance provider dedicated to small businesses, startups, independent freelancers, and contractors, has reportedly raised AUD 11 million in equity investment led by RealVC.

OVUM, a health tech platform enabling women to track their health and body symptoms using advanced technology to prevent fatal diseases, has reportedly raised AUD 1.7 million in a funding round led by Giant Leap.

WHO GIVES A CRAP, a sustainable consumer goods company specializing in eco-friendly toilet paper, paper towels, and tissues, reported AUD 264K in revenue for the FY ending June 2024, marking a 10.89% year-over-year growth. The company has seen a remarkable 1,075% increase in EBIT from the previous year, reaching AUD 8 million, highlighting strong profitability growth.
 

CHIRP (2024): A sales management platform that automates the entire sales pipeline, allowing sales leaders to focus on building relationships and maximizing selling time.
 

Access the largest and most comprehensive set of decision-makers and team members for each LP, FO, and FM profile

Register now for a demo or sign up for a free trial, no credit card required.

VC veteran leading Breakthrough Victoria into next stage.
READ FULL ARTICLE

Disrupt Radio’s fall: Unpaid wages, failed investments, and a looming court date.
READ FULL ARTICLE

Startmate selects 16 startups for its biggest Summer Accelerator yet.
READ FULL ARTICLE

Climate change means Australia has entered the ‘age of the engineer’.
READ FULL ARTICLE

Dynamo gives alternatives investors a Performance Edge by putting all their data to work to accelerate operations across front, middle, and back office. At Dynamo, we provide industry-leading solutions for the alternatives and have spent 20+ years working alongside our GP and LP clients to develop features and functionalities that allow teams to work smarter, and allowing leaders to make better investment decisions and scale their firm Dynamo has a global footprint with operations across North America, EMEA and APAC.

Ready to learn more? Request a demo today with Dynamo’s team of experts.

We are also covering the startups in Southeast Asia. To find out why the best investors use Alternatives.pe. Click the button below to subscribe to our Southeast Asia newsletter.